Place · Level 3
Andropause · Late-Onset Hypogonadism
30 后 T 缓慢降 1-2%/年 · 真低 T < 300 + 症状 · 测量陷阱 + SHBG · 生活方式优先 · TRT 适应症
Story path
Chapter 1
Not female menopause analog
Not female menopause analog
'Andropause' / 'male menopause' is a popular phrase but a poor clinical term: male hormone changes are fundamentally different from female menopause.
Female menopause (Atlas `perimenopause`):
A cliff: estrogen drops 90%+ over a few yearsClear endpoint: 12 months with no periodUniversal: all women experience it
Male hormones (LOH, late-onset hypogonadism):
Slow linear decline: testosterone falls 1–2% per year after age 30No clear endpoint; most men still have measurable testosterone at 80Not universal; only ~2% of men meet the true clinical definition (EMAS, Wu 2010 NEJM)
EMAS true LOH definition (European Male Aging Study, n=3,369):
Total T < 11 nmol/L (~320 ng/dL) + free T < 220 pmol/LPlus 3 sexual symptoms: reduced libido + reduced morning erections + erectile dysfunctionBoth criteria met → true LOH in ~2.1% of men aged 40–79Single criterion is not enough: low T without symptoms doesn't count; symptoms without low T don't either
Why does this matter?
'T clinics' + anti-aging marketing in China + US massively expand the LOH conceptA 'man tired / low energy / can't lose weight' bucket — 90% has nothing to do with testosteroneEven with low T, lifestyle factors (obesity / sleep apnea / chronic opioids / depression) account for ~90% and are reversible
Normal testosterone range (healthy adult male):
Total testosterone: 264–916 ng/dL (slight lab variation)Free T: 9–30 ng/dL (Vermeulen calculation)Morning draw (7–10 am) is the daily peak — a single low reading doesn't countRepeat at least twice, 4–6 weeks apart, to rule out transient swings
'Is a slow T decline a disease?'
Not necessarily. Compared to age 35, a normal 65-year-old man has T roughly 25–50% lower — that's physiology. The key is that symptoms + labs align before considering intervention:
Low T without symptoms: monitor, don't treatMid-range T (300–400 ng/dL) with symptoms: lifestyle first (next step)Clear LOH (low T + 3 sexual symptoms): endocrinology / urology evaluation
Female menopause (Atlas `perimenopause`):
A cliff: estrogen drops 90%+ over a few yearsClear endpoint: 12 months with no periodUniversal: all women experience it
Male hormones (LOH, late-onset hypogonadism):
Slow linear decline: testosterone falls 1–2% per year after age 30No clear endpoint; most men still have measurable testosterone at 80Not universal; only ~2% of men meet the true clinical definition (EMAS, Wu 2010 NEJM)
EMAS true LOH definition (European Male Aging Study, n=3,369):
Total T < 11 nmol/L (~320 ng/dL) + free T < 220 pmol/LPlus 3 sexual symptoms: reduced libido + reduced morning erections + erectile dysfunctionBoth criteria met → true LOH in ~2.1% of men aged 40–79Single criterion is not enough: low T without symptoms doesn't count; symptoms without low T don't either
Why does this matter?
'T clinics' + anti-aging marketing in China + US massively expand the LOH conceptA 'man tired / low energy / can't lose weight' bucket — 90% has nothing to do with testosteroneEven with low T, lifestyle factors (obesity / sleep apnea / chronic opioids / depression) account for ~90% and are reversible
Normal testosterone range (healthy adult male):
Total testosterone: 264–916 ng/dL (slight lab variation)Free T: 9–30 ng/dL (Vermeulen calculation)Morning draw (7–10 am) is the daily peak — a single low reading doesn't countRepeat at least twice, 4–6 weeks apart, to rule out transient swings
'Is a slow T decline a disease?'
Not necessarily. Compared to age 35, a normal 65-year-old man has T roughly 25–50% lower — that's physiology. The key is that symptoms + labs align before considering intervention:
Low T without symptoms: monitor, don't treatMid-range T (300–400 ng/dL) with symptoms: lifestyle first (next step)Clear LOH (low T + 3 sexual symptoms): endocrinology / urology evaluation
Symptoms — signal or noise?
The 'low T' symptom list is long, but most have weak association with testosterone.Truly T-related (EMAS + Wu 2010):
Reduced libidoReduced or absent morning erectionsReduced erectile function (ED)Muscle loss (also linked to training + protein intake)Reduced bone density (in T deficiency)
Weakly associated / multifactorial (often exaggerated by T clinics):
Fatigue: sleep / depression / chronic illness / iron deficiency / hypothyroidism are more likelyBrain fog: sleep / stress / nutritionDifficulty losing weight: diet + exercise + sleep + metabolic healthLow mood: depression + anxiety + sleepAttention problems: sleep / ADHD / stress
Key question: 'low T first, or these conditions first?'
Mostly the reverse: obesity / depression / sleep apnea directly lower testosterone, not the other way around.
Obesity: adipose-tissue aromatase converts T to estrogen + leptin feedback, T ↓ (after 5–10% weight loss, T ↑ ~15–25%)OSA (sleep apnea): hypoxia + fragmented sleep suppresses T synthesis (T rebounds after CPAP treatment)Depression + chronic stress: high cortisol suppresses the HPG axis, T ↓Long-term opioid analgesics: directly suppress the HPG axis → central low TMetabolic syndrome / T2D: SHBG ↓, so apparent total T is low (free T may still be normal)
In practice:
Symptom checklist + physical exam + lifestyle account for 80% of the evaluationLabs: morning, repeat, and concurrently measure LH + FSH + SHBG + estradiol + PSADon't jump to 'measure T then start TRT' — that's a T-clinic sales pitch, not evidence-based medicine
Chapter 2
Measure & confounders
Measure & confounders
Measuring testosterone looks simple but has multiple traps. Understanding them avoids 80% of 'low T misdiagnoses'.
Trap 1 · Time:
T has a strong circadian rhythm — morning (7–10 am) peak, afternoon and evening 30–40% lowerMust draw in the morningThis is a clinical-guideline requirement (Endocrine Society 2018 / AUA 2018)
Trap 2 · Single measurement:
T has high biological variation — the same man may show 600 one day, 350 the nextGuidelines: ≥ 2 draws, 4–6 weeks apart, both low to count
Trap 3 · Acute effects:
Acute illness (flu / cold / post-major-surgery): acute T dropIntense training + weight loss: transient T dropDon't diagnose during these periods
Trap 4 · Total T vs free T (SHBG decides everything):
Total T = SHBG-bound (98%) + free (2%)Free T is the biologically active fractionSHBG effects:SHBG ↑ (low insulin / estrogen / hyperthyroidism): total T high but free T may be normalSHBG ↓ (IR / T2D / obesity / hypothyroidism): total T low but free T may be normalThe PCOS mirror (Atlas `pcos/insulin-resistance` L4): female IR → SHBG ↓ → free T ↑ → androgen symptoms2025 consensus: borderline total T (200–400 ng/dL) should be paired with SHBG + calculated free T (Vermeulen)
Trap 5 · Lab method differences:
Direct immunoassay is cheap but inaccurate, especially at low valuesLC-MS/MS (liquid chromatography mass spectrometry) is the gold standard with good inter-lab consistencyUse LC-MS/MS preferentially; don't rely on a single immunoassay low result for diagnosis
5 reversible confounders (must be addressed before evaluation):
1. Obesity:
BMI up by 5 → T down ~100 ng/dLVisceral fat aromatase converts T → estradiolIntervention: 5–10% weight loss → T ↑ ~15–25% (Camacho 2013)
2. Sleep apnea (OSA):
Moderate–severe OSA: T 20–30% below age-matched peersIntervention: STOP-BANG questionnaire + polysomnography + CPAP, T rebounds within months
3. Long-term opioids:
Directly suppress GnRH, central low T75% of chronic opioid users have low TIntervention: discuss reduction or switching with the pain team
4. Depression + chronic stress:
Cortisol rises, suppressing the HPG axisIntervention: psychotherapy + SSRI / SNRI + CBT
5. Chronic disease (T2D / chronic liver disease / HIV / CKD)
Intervention: control the primary disease
In practice: before pursuing TRT, these 5 confounders should be addressed for 6–12 months. Most 'low T' returns to normal once the confounders are resolved.
Trap 1 · Time:
T has a strong circadian rhythm — morning (7–10 am) peak, afternoon and evening 30–40% lowerMust draw in the morningThis is a clinical-guideline requirement (Endocrine Society 2018 / AUA 2018)
Trap 2 · Single measurement:
T has high biological variation — the same man may show 600 one day, 350 the nextGuidelines: ≥ 2 draws, 4–6 weeks apart, both low to count
Trap 3 · Acute effects:
Acute illness (flu / cold / post-major-surgery): acute T dropIntense training + weight loss: transient T dropDon't diagnose during these periods
Trap 4 · Total T vs free T (SHBG decides everything):
Total T = SHBG-bound (98%) + free (2%)Free T is the biologically active fractionSHBG effects:SHBG ↑ (low insulin / estrogen / hyperthyroidism): total T high but free T may be normalSHBG ↓ (IR / T2D / obesity / hypothyroidism): total T low but free T may be normalThe PCOS mirror (Atlas `pcos/insulin-resistance` L4): female IR → SHBG ↓ → free T ↑ → androgen symptoms2025 consensus: borderline total T (200–400 ng/dL) should be paired with SHBG + calculated free T (Vermeulen)
Trap 5 · Lab method differences:
Direct immunoassay is cheap but inaccurate, especially at low valuesLC-MS/MS (liquid chromatography mass spectrometry) is the gold standard with good inter-lab consistencyUse LC-MS/MS preferentially; don't rely on a single immunoassay low result for diagnosis
5 reversible confounders (must be addressed before evaluation):
1. Obesity:
BMI up by 5 → T down ~100 ng/dLVisceral fat aromatase converts T → estradiolIntervention: 5–10% weight loss → T ↑ ~15–25% (Camacho 2013)
2. Sleep apnea (OSA):
Moderate–severe OSA: T 20–30% below age-matched peersIntervention: STOP-BANG questionnaire + polysomnography + CPAP, T rebounds within months
3. Long-term opioids:
Directly suppress GnRH, central low T75% of chronic opioid users have low TIntervention: discuss reduction or switching with the pain team
4. Depression + chronic stress:
Cortisol rises, suppressing the HPG axisIntervention: psychotherapy + SSRI / SNRI + CBT
5. Chronic disease (T2D / chronic liver disease / HIV / CKD)
Intervention: control the primary disease
In practice: before pursuing TRT, these 5 confounders should be addressed for 6–12 months. Most 'low T' returns to normal once the confounders are resolved.
Chapter 3
Lifestyle — cheapest, strongest
Lifestyle — cheapest, strongest
Lifestyle interventions for testosterone are often more impactful than TRT, are free of side effects, and yet are systematically underweighted by T clinics.
1. Weight loss (especially abdominal):
5–10% body-weight loss → T ↑ ~15–25%Waist −5 cm matters more than a BMI dropMechanism: less visceral-fat aromatase, leptin resistance reverses, IR improvesMethod: any sustainable caloric deficit + protein preservation
2. Resistance training (strength training):
2–3× per week, big compound lifts, progressive loadAcute post-workout T rises 15–30% (short-term) + long-term muscle preservationDon't chase YouTube 'T-boosting workout' marketing — standard strength training is enoughSynergistic with Atlas `protein/muscle` L4 (Leu → mechanistic target of rapamycin: The cell's master 'grow / build' switch — turned on by enough protein and resistance training. → MPS)
3. Sleep:
< 5 h/night sustained for 1 week → T ↓ 10–15%OSA treatment (CPAP) is the single most powerful intervention in confirmed cases7–9 h/night is the baseline
4. Stress management:
Chronic high cortisol suppresses the HPG axisMindfulness, diaphragmatic breathing, exercise, and social connection all lower cortisolPsychotherapy (CBT) helps stress + depression, and T rebounds indirectly
5. Moderate alcohol + no smoking:
Chronic heavy alcohol (> 21 units/week): T ↓ + estrogen ↑Smoking acutely raises T but is overall harmful (CV + cancer)
Nutrition: there is no 'T-miracle food', but ensure:
Zinc adequacy (RDA 11 mg; only supplement if deficient; oysters / red meat / pumpkin seeds)Vitamin D adequacy (25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. > 30 ng/mL; correct deficiency)Healthy fats (olive oil / fish / nuts): an ultra-low-fat diet lowers TProtein 1.2–1.6 g/kg (Atlas `protein/muscle`)No need for keto — no evidence supports it
No benefit / marketing traps:
Ashwagandha: marginal effect in chronic-stress populations, not a T boosterMaca: subjective libido improvement, no notable effect on TTribulus: multiple RCTs negativeZMA (Zn + Mg + B6 combo): no benefit in healthy people'Testosterone booster' multi-ingredient supplements: D-level evidence overallDHEA: not recommended as a T booster (side effects / inconsistent conversion)
Bottom line: most 40–60-year-old men's 'low energy / can't lose weight' improves dramatically after 6 months of lifestyle intervention, without needing to head down the TRT road.
1. Weight loss (especially abdominal):
5–10% body-weight loss → T ↑ ~15–25%Waist −5 cm matters more than a BMI dropMechanism: less visceral-fat aromatase, leptin resistance reverses, IR improvesMethod: any sustainable caloric deficit + protein preservation
2. Resistance training (strength training):
2–3× per week, big compound lifts, progressive loadAcute post-workout T rises 15–30% (short-term) + long-term muscle preservationDon't chase YouTube 'T-boosting workout' marketing — standard strength training is enoughSynergistic with Atlas `protein/muscle` L4 (Leu → mechanistic target of rapamycin: The cell's master 'grow / build' switch — turned on by enough protein and resistance training. → MPS)
3. Sleep:
< 5 h/night sustained for 1 week → T ↓ 10–15%OSA treatment (CPAP) is the single most powerful intervention in confirmed cases7–9 h/night is the baseline
4. Stress management:
Chronic high cortisol suppresses the HPG axisMindfulness, diaphragmatic breathing, exercise, and social connection all lower cortisolPsychotherapy (CBT) helps stress + depression, and T rebounds indirectly
5. Moderate alcohol + no smoking:
Chronic heavy alcohol (> 21 units/week): T ↓ + estrogen ↑Smoking acutely raises T but is overall harmful (CV + cancer)
Nutrition: there is no 'T-miracle food', but ensure:
Zinc adequacy (RDA 11 mg; only supplement if deficient; oysters / red meat / pumpkin seeds)Vitamin D adequacy (25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. > 30 ng/mL; correct deficiency)Healthy fats (olive oil / fish / nuts): an ultra-low-fat diet lowers TProtein 1.2–1.6 g/kg (Atlas `protein/muscle`)No need for keto — no evidence supports it
No benefit / marketing traps:
Ashwagandha: marginal effect in chronic-stress populations, not a T boosterMaca: subjective libido improvement, no notable effect on TTribulus: multiple RCTs negativeZMA (Zn + Mg + B6 combo): no benefit in healthy people'Testosterone booster' multi-ingredient supplements: D-level evidence overallDHEA: not recommended as a T booster (side effects / inconsistent conversion)
Bottom line: most 40–60-year-old men's 'low energy / can't lose weight' improves dramatically after 6 months of lifestyle intervention, without needing to head down the TRT road.
Practical · the 6-month lifestyle plan
The scene above listed the lifestyle factors that affect testosterone; this page arranges them into an executable 6-month plan — most 'low T symptoms' improve markedly once this is done well, never reaching the TRT step.Prioritized by value:
First priority: lose abdominal fat. If your waist is over the threshold, this is the highest-return move. A 5-10% weight loss raises testosterone roughly 15-25%, via less visceral-fat aromatase and improved insulin resistance. Track waist rather than weight.Second priority: sleep well + screen for OSA. Under 5 hours/night for a week drops testosterone 10-15%. If snoring + daytime sleepiness are present, self-screen with STOP-BANG and get a sleep study if warranted; once OSA is confirmed, CPAP is the single most powerful intervention. Restoring 7-9 hours is the baseline.Third priority: strength training + adequate protein. 2-3 sessions/week of big compound lifts with progressive load, plus protein 1.2-1.6 g/kg, to preserve muscle and improve insulin sensitivity. Don't chase 'testosterone-boosting workout' marketing — standard strength training is enough.Fourth priority: lower cortisol. Chronic high cortisol suppresses the HPG axis. Mindfulness, diaphragmatic breathing, regular exercise, and psychotherapy (CBT) all help; as mood improves, testosterone often rebounds indirectly.Baseline habits: moderate alcohol, no smoking. Long-term heavy drinking (> 21 units/week) lowers testosterone and raises estrogen.
Don't get misled on nutrition: there is no 'testosterone-miracle food'. Ensuring zinc isn't deficient (supplement only if deficient), vitamin D is adequate (25-hydroxyvitamin D: The storage form of vitamin D in blood — the number measured to check D status. > 30 ng/mL), and there's some healthy fat (an ultra-low-fat diet actually lowers testosterone) is enough. Ashwagandha / Maca / Tribulus / ZMA / assorted 'testosterone booster' blends are essentially D-level or no evidence in healthy men — don't spend money there.
How to evaluate: do this full set for 6 months before deciding whether to test testosterone or see a doctor. Addressing reversible confounders first is the evidence-based path; the reverse, 'test T then start TRT', is a T-clinic sales pitch, not medicine.
Chapter 4
TRT — indications + risks
TRT — indications + risks
TRT (testosterone replacement therapy) works in true indications, but fertility impact, cardiovascular, PSA, and erythrocyte risks are all real — the Atlas lays it out clearly.
True indications (Endocrine Society 2018):
Classical hypogonadism: structural hypothalamic-pituitary or testicular disease, congenital or acquired (Klinefelter / cryptorchidism / post-chemotherapy / pituitary tumor, etc.) — strong indicationLate-onset hypogonadism (LOH): ≥ 2 morning T < 300 ng/dL + 3 sexual symptoms (low libido + lost morning erections + ED) + 5 confounders ruled out — can considerHIV / chronic wasting / severe sarcopenia: case-by-case consideration
Real TRT effects (Snyder 2016 TTrials NEJM):
Men 65+ with low T, n=790, 1-yr RCT:
Sexual function (libido + erections + satisfaction): significantly improvedEnergy / vitality: borderlineCognition / depression: no significant effectMuscle mass / strength: small (+1.2 kg lean body mass)Bone density: improvedCardiovascular / all-cause mortality: TTrials wasn't long enough to draw conclusions
TRAVERSE (Lincoff 2023 NEJM, n=5,246):
Middle-aged and older men with low T + high CV risk, 4-yr RCT. Primary MACE: TRT vs placebo, no significant difference (HR 0.96) — that is, in low-T + high-CV-risk men, previous TRT cardiovascular safety concerns are partly alleviated. But atrial fibrillation + acute kidney injury + pulmonary embolism rose slightly.
Fertility impact (often hidden by T clinics):
TRT suppresses the HPG axis: exogenous T feeds back, shutting down LH/FSH directly, and testicular spermatogenesis stops. Almost all TRT users see sperm counts drop > 90% within 4–6 months.
Men who want fertility should not start TRT directly:
Clomiphene (50 mg every other day): indirectly stimulates the HPG axis, T rises + spermatogenesis preservedhCG (human chorionic gonadotropin): mimics LH, preserves testicular functionEnclomiphene + AI (anastrozole) combination
Wanting fertility after TRT: stop + hCG + wait 6–12 months; some irreversibility.
Other risks:
Erythrocytosis (Hct > 54%): thrombosis risk ↑, monitor + therapeutic phlebotomy as neededPSA + prostate: known prostate cancer is an absolute contraindication; monitor PSA every 3–6 monthsSleep apnea worsening: caution in patients with existing OSABreast tenderness / gynecomastia: side effects of elevated estradiolSkin acne / male-pattern hair loss: cosmetic side effects
5 TRT formulations:
Gel (Androgel / Testim): daily application, risk of contact contamination of othersInjection (T cypionate / enanthate): every 1–2 weeks, peak-to-trough fluctuationSubcutaneous small frequent injection: steadier state, self-administeredImplant pellets: 3–6 months, surgical placementNasal spray / buccal tablet: less common
In practice:
Don't use T clinics / online TRT — most lack 5-confounder screeningFind an endocrinologist or urologist for full evaluation + long-term monitoringFertility first: consider Clomiphene / hCG before TRTTRT is lifelong (once started, HPG recovery is unreliable)
True indications (Endocrine Society 2018):
Classical hypogonadism: structural hypothalamic-pituitary or testicular disease, congenital or acquired (Klinefelter / cryptorchidism / post-chemotherapy / pituitary tumor, etc.) — strong indicationLate-onset hypogonadism (LOH): ≥ 2 morning T < 300 ng/dL + 3 sexual symptoms (low libido + lost morning erections + ED) + 5 confounders ruled out — can considerHIV / chronic wasting / severe sarcopenia: case-by-case consideration
Real TRT effects (Snyder 2016 TTrials NEJM):
Men 65+ with low T, n=790, 1-yr RCT:
Sexual function (libido + erections + satisfaction): significantly improvedEnergy / vitality: borderlineCognition / depression: no significant effectMuscle mass / strength: small (+1.2 kg lean body mass)Bone density: improvedCardiovascular / all-cause mortality: TTrials wasn't long enough to draw conclusions
TRAVERSE (Lincoff 2023 NEJM, n=5,246):
Middle-aged and older men with low T + high CV risk, 4-yr RCT. Primary MACE: TRT vs placebo, no significant difference (HR 0.96) — that is, in low-T + high-CV-risk men, previous TRT cardiovascular safety concerns are partly alleviated. But atrial fibrillation + acute kidney injury + pulmonary embolism rose slightly.
Fertility impact (often hidden by T clinics):
TRT suppresses the HPG axis: exogenous T feeds back, shutting down LH/FSH directly, and testicular spermatogenesis stops. Almost all TRT users see sperm counts drop > 90% within 4–6 months.
Men who want fertility should not start TRT directly:
Clomiphene (50 mg every other day): indirectly stimulates the HPG axis, T rises + spermatogenesis preservedhCG (human chorionic gonadotropin): mimics LH, preserves testicular functionEnclomiphene + AI (anastrozole) combination
Wanting fertility after TRT: stop + hCG + wait 6–12 months; some irreversibility.
Other risks:
Erythrocytosis (Hct > 54%): thrombosis risk ↑, monitor + therapeutic phlebotomy as neededPSA + prostate: known prostate cancer is an absolute contraindication; monitor PSA every 3–6 monthsSleep apnea worsening: caution in patients with existing OSABreast tenderness / gynecomastia: side effects of elevated estradiolSkin acne / male-pattern hair loss: cosmetic side effects
5 TRT formulations:
Gel (Androgel / Testim): daily application, risk of contact contamination of othersInjection (T cypionate / enanthate): every 1–2 weeks, peak-to-trough fluctuationSubcutaneous small frequent injection: steadier state, self-administeredImplant pellets: 3–6 months, surgical placementNasal spray / buccal tablet: less common
In practice:
Don't use T clinics / online TRT — most lack 5-confounder screeningFind an endocrinologist or urologist for full evaluation + long-term monitoringFertility first: consider Clomiphene / hCG before TRTTRT is lifelong (once started, HPG recovery is unreliable)
Myth · 'TRT will make me 25 again'
What T clinics and anti-aging marketing love to sell is the picture: one testosterone shot and energy, muscle, libido, brainpower, and mood all rejuvenate. Set that against the actual trial data and the image turns out heavily airbrushed.What TRT is genuinely supported to do (Snyder 2016 TTrials, 65+ low-T men, 1-year RCT):
Sexual function: libido, erections, and satisfaction improve significantly — TRT's most certain benefit.Muscle mass / strength: only small (~ +1.2 kg lean body mass), far from the marketing's 'effortless gains'.Bone density: improved.Energy / vitality: a borderline, unstable effect.Cognition / depression: no significant effect — this one directly punctures the common claim that 'TRT fixes brain fog and low mood'.
Several costs the marketing quietly downplays:
Fertility impact: exogenous testosterone feeds back and shuts down LH/FSH, so almost all TRT users see sperm drop > 90% within 4-6 months, partly irreversibly. People who want fertility should not start TRT directly — consider Clomiphene / hCG first. T clinics often omit this.Erythrocytosis: rising hematocrit raises thrombosis risk, requiring monitoring and phlebotomy as needed.Prostate: known prostate cancer is an absolute contraindication; monitor PSA periodically on therapy.Lifelong dependence: once started, the HPG axis doesn't recover easily — it's essentially lifelong treatment.
So the accurate picture: TRT works in true indications (classical hypogonadism, or ≥ 2 morning T < 300 + 3 sexual symptoms + the 5 confounders ruled out), with the main payoff in sexual function and bone. But for someone who 'just wants more energy / to feel young again' yet doesn't meet guideline criteria, the evidence-based answer is to complete the 6-month lifestyle plan above first — not to get a shot at a T clinic. Treat TRT as a prescription drug for a specific deficit, not an anti-aging supplement.
Chapter 5
Decision tree + atlas loop
Decision tree + atlas loop
'Am I low on T?' self-check + decision tree
Step 1 · Self-check
Tick the following — at least 3 are needed before T testing is warranted:
Significantly reduced libido for ≥ 6 monthsSignificantly reduced or absent morning erectionsReduced erectile functionUnexplained loss of muscle strength (with training + diet unchanged)Chronic fatigue (after excluding sleep / depression / chronic illness)Unexplained weight gain (especially abdominal)
Fewer than 3 ticked: don't test T — focus on lifestyle + sleep + psychology.
Step 2 · Address the 5 confounders
BMI > 30 or waist > 102 cm (male): lose 5–10% firstSnoring + daytime sleepiness: STOP-BANG OSA evaluationLong-term opioids / sedatives: discuss with the prescribing physicianChronic stress + mood problems: psychotherapy + CBTT2D / chronic disease: control the primary disease
Resolve these for 6–12 months first, then evaluate T.
Step 3 · Labs (if you still want to measure)
Morning 7–10 amNot within 2 weeks of acute illness / surgery, or on a day of extreme trainingTotal T + free T (Vermeulen) + SHBG + LH + FSH + estradiol + PSAMethod: LC-MS/MSRepeat once, 4–6 weeks apart
Step 4 · Interpretation
Total T > 400 ng/dL: normal, look for other causesTotal T 300–400 + free T normal: borderline SHBG issue, no TRT neededTotal T < 300 on ≥ 2 occasions + sexual symptoms ≥ 3 + confounders addressed: endocrinology / urology evaluationTotal T < 200: abnormal regardless of confounders, evaluate
Step 5 · Treatment path
Classical hypogonadism: TRTLOH + wanting fertility: Clomiphene / hCG (not TRT)LOH + no fertility plans: discuss TRT formulation + monitoring with physician'Just want more energy' but doesn't meet guideline criteria: lifestyle first, not TRT
Situations to see a doctor promptly
Breast pain + lump (rule out breast cancer / gynecomastia)Visual field constriction + headache (rule out pituitary tumor)Unexplained PSA rise (prostate evaluation)Sudden severe fatigue + significant weight loss (chronic-disease screen)Infertility + low T (reproductive urology)
Atlas + Report loop
The report engine `fertility-prep-male` rule links back here. Atlas links out to:
`protein/muscle` L4 — sarcopenia + Leu/mechanistic target of rapamycin: The cell's master 'grow / build' switch — turned on by enough protein and resistance training.`bone/hormones` L4 — T maintains bone mass`endocrine/metabolic-syndrome` L4 — IR + weight loss restores T`cardiovascular/atherosclerosis` L4 — T + LDL`insomnia/what-types` L4 — sleep raises T
Bottom line: andropause is a real phenomenon (slow T decline) with a misleading name (not a menopause analog). True LOH affects only ~2%; most 'low T symptoms' improve dramatically with lifestyle intervention. The T clinic industry has systematically expanded indications; the Atlas brings it back to an evidence-based 'true indication + comprehensive evaluation + long-term monitoring' framework.
Step 1 · Self-check
Tick the following — at least 3 are needed before T testing is warranted:
Significantly reduced libido for ≥ 6 monthsSignificantly reduced or absent morning erectionsReduced erectile functionUnexplained loss of muscle strength (with training + diet unchanged)Chronic fatigue (after excluding sleep / depression / chronic illness)Unexplained weight gain (especially abdominal)
Fewer than 3 ticked: don't test T — focus on lifestyle + sleep + psychology.
Step 2 · Address the 5 confounders
BMI > 30 or waist > 102 cm (male): lose 5–10% firstSnoring + daytime sleepiness: STOP-BANG OSA evaluationLong-term opioids / sedatives: discuss with the prescribing physicianChronic stress + mood problems: psychotherapy + CBTT2D / chronic disease: control the primary disease
Resolve these for 6–12 months first, then evaluate T.
Step 3 · Labs (if you still want to measure)
Morning 7–10 amNot within 2 weeks of acute illness / surgery, or on a day of extreme trainingTotal T + free T (Vermeulen) + SHBG + LH + FSH + estradiol + PSAMethod: LC-MS/MSRepeat once, 4–6 weeks apart
Step 4 · Interpretation
Total T > 400 ng/dL: normal, look for other causesTotal T 300–400 + free T normal: borderline SHBG issue, no TRT neededTotal T < 300 on ≥ 2 occasions + sexual symptoms ≥ 3 + confounders addressed: endocrinology / urology evaluationTotal T < 200: abnormal regardless of confounders, evaluate
Step 5 · Treatment path
Classical hypogonadism: TRTLOH + wanting fertility: Clomiphene / hCG (not TRT)LOH + no fertility plans: discuss TRT formulation + monitoring with physician'Just want more energy' but doesn't meet guideline criteria: lifestyle first, not TRT
Situations to see a doctor promptly
Breast pain + lump (rule out breast cancer / gynecomastia)Visual field constriction + headache (rule out pituitary tumor)Unexplained PSA rise (prostate evaluation)Sudden severe fatigue + significant weight loss (chronic-disease screen)Infertility + low T (reproductive urology)
Atlas + Report loop
The report engine `fertility-prep-male` rule links back here. Atlas links out to:
`protein/muscle` L4 — sarcopenia + Leu/mechanistic target of rapamycin: The cell's master 'grow / build' switch — turned on by enough protein and resistance training.`bone/hormones` L4 — T maintains bone mass`endocrine/metabolic-syndrome` L4 — IR + weight loss restores T`cardiovascular/atherosclerosis` L4 — T + LDL`insomnia/what-types` L4 — sleep raises T
Bottom line: andropause is a real phenomenon (slow T decline) with a misleading name (not a menopause analog). True LOH affects only ~2%; most 'low T symptoms' improve dramatically with lifestyle intervention. The T clinic industry has systematically expanded indications; the Atlas brings it back to an evidence-based 'true indication + comprehensive evaluation + long-term monitoring' framework.